Good news | Baisaifei was shortlisted for the national biomedical materials innovation task 'unveiling the list and taking charge' list, and was named on the double list!

On August 26, the Ministry of Industry and Information Technology and the State Food and Drug Administration jointly announced the list of biomedical materials innovation tasks (second batch) shortlisted for the list (86 items nationwide). Bysaifei was nominated for the two innovation tasks of phosphoryl choline-based polymer and new anti-thrombotic material ε-lysine-based polymer. The industrial application of anticoagulant coatings on domestic blood-contacting devices (such as vascular stents, ECMO, etc.) lags behind foreign countries for more than 40 years. Mass production processes and innovative design breakthroughs in key coating materials are one of the important assists for domestic devices to catch up with international standards, and even achieve overtaking in corners and lead the world. In this 'unveiling the list' task, based on more than 20 years of basic research on biomaterial surface interfaces and nearly ten years of coating technology transformation experience, Baisaifei focused on the innovation and industrial application direction of anticoagulant coatings, and successfully unveiled the 'stuck neck' raw material of the anticoagulant coating - medical grade 'phosphorylcholine-based polymer' innovation task, as well as the internationally recognized